The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Authors
Keywords
Cellular immunity, Coronavirus disease 2019, Interferon-γ release assay, Severe acute respiratory syndrome coronavirus 2, T cell, Tuberculosis
Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-11
DOI
10.1016/j.cmi.2021.07.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Mapping and role of T cell response in SARS-CoV-2–infected mice
- (2021) Zhen Zhuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T cell response to SARS-CoV-2 infection in humans: A systematic review
- (2021) Madhumita Shrotri et al. PLoS One
- Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
- (2021) Anthony T. Tan et al. Cell Reports
- Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
- (2021) Nina Le Bert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
- (2021) Jianmin Zuo et al. NATURE IMMUNOLOGY
- Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
- (2021) Alessandra Aiello et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- Fourth generation QuantiFERON-TB Gold-Plus: What is the evidence?
- (2020) Arena Shafeque et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
- (2020) Annarosa Soresina et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis
- (2020) Guozhong Zhou et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19
- (2020) Miao Luo et al. JCI Insight
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response
- (2020) Kanagavel Murugesan et al. CLINICAL INFECTIOUS DISEASES
- A whole blood test to measure SARS-CoV-2 specific response in COVID-19 patients
- (2020) Linda Petrone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell immunobiology and cytokine storm of COVID‐19
- (2020) Xiao‐Hua Luo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study
- (2019) Hilary S Whitworth et al. LANCET INFECTIOUS DISEASES
- The generation of T cell memory to protect against Tuberculosis
- (2019) Claudio Counoupas et al. IMMUNOLOGY AND CELL BIOLOGY
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-γ Release Assays in Children
- (2019) Amina Ahmed et al. PEDIATRICS
- Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan
- (2018) Jin Takasaki et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- The CD8 T Cell Response to Respiratory Virus Infections
- (2018) Megan E. Schmidt et al. Frontiers in Immunology
- Airway T cells protect against RSV infection in the absence of antibody
- (2017) E Kinnear et al. Mucosal Immunology
- Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study
- (2016) Paul Gillard et al. TUBERCULOSIS
- Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production
- (2015) Sean R. McMaster et al. JOURNAL OF IMMUNOLOGY
- Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
- (2014) M. Pai et al. CLINICAL MICROBIOLOGY REVIEWS
- Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults
- (2013) Cheryl L. Day et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now